Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
Epithalon (EPT) is a anti-aging peptide, at the preclinical stage in the published literature. Synthetic tetrapeptide based on the natural pineal peptide Epithalamin. Activates telomerase and may have anti-aging properties.
Synthetic tetrapeptide based on the natural pineal peptide Epithalamin. Activates telomerase and may have anti-aging properties.
| Research Status | Preclinical |
|---|---|
| Half-Life | Unknown |
| Administration | Subcutaneous injection |
| Doses Reported in Published Studies | 5-10 mg daily |
Telomerase activation, melatonin regulation, antioxidant activity, pineal gland stimulation.
Synthetic tetrapeptide based on the natural pineal peptide Epithalamin. Activates telomerase and may have anti-aging properties.
Telomerase activation, melatonin regulation, antioxidant activity, pineal gland stimulation.
Epithalon is at the following stage in the published literature: Preclinical. All information is for research and educational purposes only.
Reported half-life: Unknown.
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.